ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 240 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2023. The put-call ratio across all filers is 2.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $556 | +0.9% | 42,336 | -3.2% | 0.01% | +25.0% |
Q2 2023 | $551 | -8.5% | 43,754 | -5.2% | 0.00% | -20.0% |
Q1 2023 | $602 | -32.1% | 46,136 | -8.2% | 0.01% | -37.5% |
Q4 2022 | $886 | -99.9% | 50,248 | -1.0% | 0.01% | +14.3% |
Q3 2022 | $773,000 | -0.1% | 50,731 | -2.8% | 0.01% | 0.0% |
Q2 2022 | $774,000 | -37.8% | 52,214 | -5.5% | 0.01% | -30.0% |
Q1 2022 | $1,245,000 | -41.9% | 55,273 | -52.4% | 0.01% | +25.0% |
Q4 2021 | $2,144,000 | +167.0% | 116,168 | +93.3% | 0.01% | +14.3% |
Q3 2021 | $803,000 | -36.8% | 60,085 | -12.4% | 0.01% | -30.0% |
Q2 2021 | $1,270,000 | +479.9% | 68,592 | +371.0% | 0.01% | +25.0% |
Q1 2021 | $219,000 | -3.1% | 14,564 | -6.9% | 0.01% | -11.1% |
Q4 2020 | $226,000 | +75.2% | 15,642 | -1.5% | 0.01% | +50.0% |
Q3 2020 | $129,000 | +18.3% | 15,876 | -0.9% | 0.01% | +20.0% |
Q2 2020 | $109,000 | -42.0% | 16,028 | -40.1% | 0.01% | 0.0% |
Q1 2020 | $188,000 | -30.1% | 26,767 | -2.2% | 0.01% | 0.0% |
Q4 2019 | $269,000 | -4.9% | 27,359 | +6.3% | 0.01% | -16.7% |
Q3 2019 | $283,000 | -7.5% | 25,747 | -2.1% | 0.01% | -14.3% |
Q2 2019 | $306,000 | +21.9% | 26,295 | -0.1% | 0.01% | +16.7% |
Q1 2019 | $251,000 | +2.4% | 26,326 | +3.4% | 0.01% | -14.3% |
Q4 2018 | $245,000 | -28.2% | 25,449 | +6.3% | 0.01% | -12.5% |
Q3 2018 | $341,000 | +7.6% | 23,948 | -9.3% | 0.01% | 0.0% |
Q2 2018 | $317,000 | -0.6% | 26,390 | +2.3% | 0.01% | 0.0% |
Q1 2018 | $319,000 | -16.3% | 25,792 | -1.4% | 0.01% | -20.0% |
Q4 2017 | $381,000 | +9.5% | 26,167 | +6.9% | 0.01% | -9.1% |
Q3 2017 | $348,000 | +5.5% | 24,467 | -5.5% | 0.01% | 0.0% |
Q2 2017 | $330,000 | -12.0% | 25,890 | -12.4% | 0.01% | -42.1% |
Q1 2017 | $375,000 | +28.0% | 29,551 | +3.0% | 0.02% | +46.2% |
Q4 2016 | $293,000 | -12.3% | 28,683 | +13.0% | 0.01% | -31.6% |
Q3 2016 | $334,000 | -2.1% | 25,383 | -0.0% | 0.02% | -5.0% |
Q2 2016 | $341,000 | +17.2% | 25,384 | +15.3% | 0.02% | -28.6% |
Q1 2016 | $291,000 | -6.4% | 22,017 | +9.0% | 0.03% | -26.3% |
Q4 2015 | $311,000 | +16.0% | 20,202 | -6.4% | 0.04% | +35.7% |
Q3 2015 | $268,000 | -7.6% | 21,587 | +1.7% | 0.03% | 0.0% |
Q2 2015 | $290,000 | +116.4% | 21,224 | +89.5% | 0.03% | +75.0% |
Q1 2015 | $134,000 | 0.0% | 11,198 | +6.6% | 0.02% | -23.8% |
Q4 2014 | $134,000 | -3.6% | 10,503 | +1.1% | 0.02% | 0.0% |
Q3 2014 | $139,000 | -15.2% | 10,384 | +1.6% | 0.02% | -16.0% |
Q2 2014 | $164,000 | – | 10,224 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 10,507,149 | $138,799,000 | 8.42% |
Tamarack Advisers, LP | 1,650,000 | $21,797,000 | 7.63% |
Blue Harbour Group | 10,759,695 | $142,136,000 | 4.78% |
BROADVIEW ADVISORS LLC | 1,095,800 | $14,476,000 | 2.08% |
Rovida Advisors Inc. | 752,400 | $9,939,000 | 2.04% |
Adirondack Research & Management Inc. | 361,259 | $4,772,000 | 1.73% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,104,400 | $14,589,000 | 1.70% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 14,401,161 | $190,239,000 | 1.62% |
FULLER & THALER ASSET MANAGEMENT, INC. | 5,077,304 | $67,071,000 | 1.30% |
Iguana Healthcare Management, LLC | 250,000 | $3,303,000 | 1.21% |